Kewaunee to Buy Nycom for $55M Base Price, Adding $20M Seller Note and $5M Stock
KEQU is trading near its 52-week low of $32 (1.0% above the low) on elevated volume (2.7× avg).
Summary
Kewaunee agreed to acquire Nycom, the largest U.S. lab dealer, for a $55 million base price paid with $30 million cash, a $20 million subordinated seller note and $5 million in newly issued stock. The deal is expected to close in the fourth quarter of fiscal 2027.
Key Events · M&A and Partnerships · KEQU
-
Nycom Acquired for $55M Base Price
Kewaunee will buy 100% of Nycom, the largest lab dealer in the USA, for an initial purchase price of $55,000,000, subject to EBITDA and working capital adjustments.
-
Cash, Seller Note and Stock Split
$30,000,000 is payable in cash at closing (including $1,000,000 into escrow, funded in part by PNC Bank debt), $20,000,000 via a subordinated seller note and $5,000,000 in newly issued Kewaunee common stock subject to a 12-month lock-up.
-
Earn-Out and Termination Floor
Price rises by 5x any adjusted EBITDA above $11,000,000 and falls by 5x any shortfall below the $9,300,000 target; either side can terminate if estimated adjusted EBITDA is below $8,000,000.
-
Board Seat and Employment Terms
Jonathan F. Nystrom joins Kewaunee's board at closing and Jonathan G. Nystrom signs a five-year employment agreement as an Executive Vice President; key Nycom employees get retention restricted stock vesting on the second anniversary.
Analysis · KEQU · Industrial Applications And Services
Kewaunee is buying Nycom, its largest U.S. lab dealer, for a $55 million base price — roughly 57% of the company's entire market value — which makes this a thesis-changing deal rather than a bolt-on. Only $30 million is cash at closing (partly PNC-funded), $20 million is a subordinated seller note and $5 million is new Kewaunee stock locked up for 12 months, so the balance sheet absorbs less cash than the headline suggests but the company takes on real leverage and a seller who is now a shareholder. The price moves with Nycom's adjusted EBITDA: above $11 million Kewaunee pays 5x the excess, below the $9.3 million target the seller gives back 5x the shortfall, and the deal can be terminated if estimated EBITDA comes in under $8 million. Closing is targeted for the fourth quarter of fiscal 2027, subject to a March 31, 2027 outside date.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KEQU was trading at $32.33 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $96.8M. The 52-week trading range was $32.00 to $44.47. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.